![Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez](https://www.jahjournal.org/articles/2015/6/2/images/JApplHematol_2015_6_2_43_160196_u4.jpg)
Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
![Table 4 from Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine. | Semantic Scholar Table 4 from Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba809701287fa62da146b7acf9c5207aba8f6e86/4-Table4-1.png)
Table 4 from Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine. | Semantic Scholar
![Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies](http://www.scielo.br/img/revistas/rbhh/v38n1//1516-8484-rbhh-38-01-0037-gf01.jpg)
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies
![A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay](https://www.oatext.com/img/HMO-4-195-g003.gif)
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
![Urine immunofixation test showed the monoclonal-free kappa light chains. | Download Scientific Diagram Urine immunofixation test showed the monoclonal-free kappa light chains. | Download Scientific Diagram](https://www.researchgate.net/publication/320808547/figure/fig3/AS:556307908395008@1509645549781/Urine-immunofixation-test-showed-the-monoclonal-free-kappa-light-chains.png)
Urine immunofixation test showed the monoclonal-free kappa light chains. | Download Scientific Diagram
![Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies](http://www.scielo.br/img/revistas/rbhh/v38n1//1516-8484-rbhh-38-01-0037-gf02.jpg)